港股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

醫藥外包概念

2,759.740

+17.3530.63%

漲家數：6

跌家數：2

平家數：- -

市盈率：- -

高：2,793.113

開：2,747.468

低：2,738.391

收：2,742.387

成交量：4,974.71萬

成交額：17.06億

市值：6,751.03億

流通市值：2,725.74億

資料載入中...

總覽新聞資訊

富國基金朱少醒旗下基金年報：重倉製造業，藥明康德(603259.SH)獲加倉

康龍化成：製劑商業化車間投產獲國際大藥企訂單小分子CDMO毛利率有望提升

每日经济新闻

泰格醫藥：與某全球龍頭MNC簽署戰略合作協議參與其全球早期臨床研究策略制定

「藥明系」股價集體上行藥明合聯(02268)漲6.10%

港股異動 | 康龍化成(03759)升逾7% 公司整體業績積極提速去年新簽訂單金額同增超14%

藥明康德(02359)出現大手賣出19.04萬股，成交價$124.0，涉資2.361千萬

阿斯达克财经

去年下半年增持昭衍新藥、建倉特寶生物中歐基金葛蘭自購旗下獨管醫藥基金

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK1576/news?page=2"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1576","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1576\",,,,,undefined,":{"symbol":"BK1576","market":"HK","secType":"PLATE","nameCN":"醫藥外包概念","latestPrice":2759.74,"timestamp":1776326890394,"preClose":2742.3867,"halted":0,"volume":49747143,"delay":0,"changeRate":0.006328,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盤","change":17.353271,"latestTime":"04-16 16:00:00","open":2747.468,"high":2793.113,"low":2738.3906,"amount":1705668504,"amplitude":0.019954,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1776389400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1776303000000,1776312000000],[1776315600000,1776326400000]],"pbRate":2.998909,"peRate":26.07184,"turnoverRate":0.004071,"increases":6,"decrements":2,"flats":0,"marketCap":675102871168,"floatMarketCap":272573826432},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1576\",,,,,undefined,":{"symbol":"BK1576","high":2793.113,"amplitude":0.019954,"preClose":2742.3867,"low":2738.3906,"pbRate":"2.998909","latestPrice":2759.74,"volume":49747143,"delay":0,"open":2747.468,"prevYearClose":2300.936,"prevWeekClose":2678.901,"prevMonthClose":2439.167,"prevQuarterClose":2439.167,"fiveDayClose":2655.588,"twentyDayClose":2473.841,"sixtyDayClose":2844.954,"secType":"PLATE","market":"HK","turnoverRate":0.004071,"peRate":26.07184,"marketCap":675102871168,"floatMarketCap":272573826432,"timestamp":1776326890394,"nameCN":"醫藥外包概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1576\",,,,undefined,":{"bkCode":"BK1576","up":6,"down":2,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1576\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2624202513","title":"富國基金朱少醒旗下基金年報：重倉製造業，藥明康德(603259.SH)獲加倉","url":"https://stock-news.laohu8.com/highlight/detail?id=2624202513","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624202513?lang=zh_tw&edition=fundamental","pubTime":"2026-04-01 20:09","pubTimestamp":1775045360,"startTime":"0","endTime":"0","summary":"从持仓动向看，赛轮轮胎、思泉新材、药明康德、泽璟制药、寒武纪获进一步加仓，而滨江集团、骄成超声、立讯精密遭减持。行业分布方面，富国天惠精选成长重仓制造业，公允价值达163.74亿元，占基金资产净值比例72.82%。朱少醒在年报中分析称，2025市场投资热度大幅上升，投资热点扩散。朱少醒指出，经过2025年的全面上涨，市场整体估值有显著抬升，部分热门板块甚至已经泡沫隐现。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1424183.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0216","LU0456842615.SGD","603259","02359","BK1583","BK1576","LU2125910500.SGD","LU0708995583.HKD","LU0052750758.USD","LU1997245094.SGD","LU1997244956.HKD","LU1997245177.USD","LU2242644610.SGD","BK1141","LU1934453819.USD","LU0320764599.SGD","LU2328871848.SGD","LU1969619763.USD","LU1046422090.SGD","LU2045819591.USD","LU2495084118.USD","LU2488822045.USD","LU1808992512.USD","LU1979443071.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624299599","title":"康龍化成：製劑商業化車間投產獲國際大藥企訂單 小分子CDMO毛利率有望提升","url":"https://stock-news.laohu8.com/highlight/detail?id=2624299599","media":"每日经济新闻","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624299599?lang=zh_tw&edition=fundamental","pubTime":"2026-04-01 17:16","pubTimestamp":1775034962,"startTime":"0","endTime":"0","summary":"每经AI快讯，4月1日，康龙化成(300759.SZ)发布投资者关系活动记录表公告，公司位于北京第二园区的制剂商业化生产车间建设完成，并于2026年第一季度与一家国际大型制药公司签订战略合作协议，为其首个注册申报的口服小分子GLP-1受体激动剂提供商业化生产服务。报告期内，公司新签订单金额同比增长超过14%，新增客户超过950家，活跃客户超过3,300家。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202604013691983183.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604013691983183.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["03759","BK1576","BK0216","BK1141","BK4139","CDMO","300759"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624595533","title":"泰格醫藥：與某全球龍頭MNC簽署戰略合作協議 參與其全球早期臨床研究策略制定","url":"https://stock-news.laohu8.com/highlight/detail?id=2624595533","media":"人民财讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624595533?lang=zh_tw&edition=fundamental","pubTime":"2026-04-01 16:19","pubTimestamp":1775031540,"startTime":"0","endTime":"0","summary":"【泰格医药：与某全球龙头MNC签署战略合作协议 参与其全球早期临床研究策略制定】泰格医药3月30日在业绩说明会上表示，开年业务亮点：与某全球龙头MNC签署战略合作协议，参与其全球早期临床研究策略制定，提供全方位支持。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604013691912750.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0174","BK0028","BK1141","BK1576","BK0216","300347","BK0077","LU1146622755.USD","LU1820825898.SGD","03347","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624887564","title":"「藥明系」股價集體上行 藥明合聯(02268)漲6.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2624887564","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624887564?lang=zh_tw&edition=fundamental","pubTime":"2026-04-01 13:21","pubTimestamp":1775020892,"startTime":"0","endTime":"0","summary":"金吾财讯 | “药明系”股价集体上行，药明合联(02268)涨6.10%，药明生物(02269)涨6.06%，药明康德(02359)涨5.45%，药明巨诺-B(02126)涨5.21%。开源证券表示，“药明系”三家公司均对2026年增长给出积极展望：2026年，药明康德持续经营业务收入指引同比增长18–22%，CAPEX进一步提升至65–75亿元；药明生物预计收入实现同比增长13–17%（已包含汇率影响）；药明合联设立2025–2030年30–35%CAGR目标。整体来看，三家龙头在不同细分赛道均给出较强增长指引，反映CXO在订单、产能与需求端共振下的景气延续性进一步强化。","market":"fut","thumbnail":"https://static.szfiu.com/news/20241108/MzQyYjVhODQ3ZWY1M2M1MGY5NWIyMTYzODE1MzIxNzE=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MzQyYjVhODQ3ZWY1M2M1MGY5NWIyMTYzODE1MzIxNzE=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1978035","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1242518931.SGD","LU1046422090.SGD","LU0140636845.USD","LU0307460666.USD","LU0320764599.SGD","BK1521","BK1583","LU0516423091.SGD","LU0516423174.USD","LU0417516738.SGD","LU0823426480.USD","LU0856984785.SGD","LU0516422366.SGD","LU0516422440.USD","LU0819121731.USD","LU0516422952.EUR","SG9999002562.SGD","LU1880383366.USD","02268","BK1161","LU2039709279.SGD","LU0979878070.USD","LU3063872942.SGD","SG9999014674.SGD","LU2125910500.SGD","BK1589","LU0572944931.SGD","LU0359201612.USD","LU0348825331.USD","BK1610","BK1576","LU0359202008.SGD","02359","LU0326950275.SGD","LU0039217434.USD","02269","LU0181495838.USD","02126","LU1794554557.SGD","SG9999002463.SGD","BK1141","LU0348735423.USD","LU2488822045.USD","LU0708995583.HKD","LU0043850808.USD","LU0456827905.SGD","LU0823426308.USD","IE00B0JY6N72.USD","LU0051755006.USD","LU2242644610.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624256822","title":"港股異動 | 康龍化成(03759)升逾7% 公司整體業績積極提速 去年新簽訂單金額同增超14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2624256822","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624256822?lang=zh_tw&edition=fundamental","pubTime":"2026-04-01 10:18","pubTimestamp":1775009909,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，康龙化成涨超7%，截至发稿，涨7.12%，报20.16港元，成交额9477.65万港元。消息面上，康龙化成2025年度业绩显示，收益140.95亿元，同比增长14.8%；母公司拥有人应占利润16.64亿元，同比下降7.2%。单看第四季度，其中2025年第四季度，公司单季度主营收入40.09亿元，同比上升15.93%；归母净利润5.23亿元，同比上升40.76%。华泰证券认为，公司整体业绩积极提速。公司客户询单量持续向好，25年新签订单金额同比增长超14%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1423752.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0216","BK1141","03759","BK4588","300759","BK1576","VXUS","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624637550","title":"藥明康德(02359)出現大手賣出19.04萬股，成交價$124.0，涉資2.361千萬","url":"https://stock-news.laohu8.com/highlight/detail?id=2624637550","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624637550?lang=zh_tw&edition=fundamental","pubTime":"2026-04-01 09:20","pubTimestamp":1775006400,"startTime":"0","endTime":"0","summary":"[大手成交]药明康德(02359)在上午09:20出现大手卖出，成交量为19.04万，成交价为港币$124.0，涉资2.361千万。至目前为止，股价升5.532%，今日最高价为$124.0，而最低价为$124.0，总成交量为19.047万股，总成交金额港币$2.362千万。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180815142908460_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180815142908460_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT26040183/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT26040183/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["LU1046422090.SGD","BK0216","LU0320764599.SGD","BK1583","LU0456842615.SGD","LU1997244956.HKD","LU2045819591.USD","LU0052750758.USD","LU1997245094.SGD","LU2125910500.SGD","BK1576","LU2495084118.USD","02359","603259","LU1808992512.USD","BK1141","LU1969619763.USD","LU2488822045.USD","LU1979443071.USD","LU0708995583.HKD","LU1997245177.USD","LU2328871848.SGD","LU1934453819.USD","LU2242644610.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624543215","title":"去年下半年增持昭衍新藥、建倉特寶生物 中歐基金葛蘭自購旗下獨管醫藥基金","url":"https://stock-news.laohu8.com/highlight/detail?id=2624543215","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624543215?lang=zh_tw&edition=fundamental","pubTime":"2026-04-01 07:27","pubTimestamp":1774999620,"startTime":"0","endTime":"0","summary":"2025年下半年，葛兰旗下3只基金的内部持有情况出现明显分化。3月31日，中欧基金投资总监、明星基金经理葛兰在管的3只公募基金披露2025年报，其隐形重仓股也随之曝光。具体来看，同为医药主题的中欧医疗健康、中欧医疗创新均大幅增持了昭衍新药，同时中欧医疗创新还重新买回了奥浦迈、博腾股份、三生国健，并首次建仓特宝生物。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202604013690999074.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604013690999074.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1576","BK1141","06127","BK0216","688278","160635","603127","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":27,"code":"91000000","status":"200"}]}}